Liothyronine Sodium Roma Pharmaceuticals

Liothyronine Sodium, the active ingredient in Liothyronine Sodium Roma Pharmaceuticals, is a thyroid hormone presented as an oral tablet for oral use. It is used to treat hypothyroidism, myxedema coma, and to provide thyroid hormone replacement after thyroidectomy. GNH USA supplies Liothyronine Sodium Roma Pharmaceuticals as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Liothyronine Sodium is employed in thyroid hormone replacement therapy to correct deficient T3 levels across several clinical scenarios.

Hypothyroidism: restores normal metabolic rate and alleviates symptoms of low thyroid function. Myxedema coma: provides rapid T3 supplementation in life‑threatening thyroid failure. Post‑thyroidectomy replacement: supplies physiologic T3 after surgical removal of the thyroid gland.

Liothyronine Sodium may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Palpitations or rapid heart rate - Anxiety or nervousness - Heat intolerance and excessive sweating - Insomnia or difficulty sleeping - Weight loss or decreased appetite - Tremor of the hands

Serious or Rare Side Effects: - Cardiac arrhythmias, including atrial fibrillation - Myocardial ischemia or angina in susceptible patients - Severe hypertension or hypertensive crisis - Osteoporosis or accelerated bone loss with long‑term use - Allergic reactions such as rash, pruritus, or angioedema - Thyrotoxicosis leading to severe metabolic disturbances

When prescribing Liothyronine Sodium, clinicians should consider several safety measures.

Dose adjustment: monitor thyroid function tests regularly and titrate dose accordingly. Cardiovascular disease: use with caution in patients with coronary artery disease or arrhythmias. Elderly patients: initiate therapy at lower doses to reduce risk of cardiac stress. Pregnancy and lactation: safety not established; evaluate risk‑benefit before use. Drug interactions: review concomitant medications for potential antagonism or potentiation. Store at ambient temperature: keep in original container, protect from moisture and light.

Liothyronine Sodium can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Amiodarone: may exacerbate thyroid dysfunction and alter T3 levels. - Antithyroid drugs (methimazole, propylthiouracil): antagonize the therapeutic effect of Liothyronine. - Beta‑blockers: can mask symptoms of excess thyroid hormone.

Moderate Interactions (Monitor Closely): - Warfarin: Liothyronine may affect INR, requiring closer monitoring. - Corticosteroids: can increase metabolism of T3, potentially reducing effectiveness. - Estrogen‑containing oral contraceptives: raise thyroid‑binding globulin, possibly necessitating dose adjustment.